Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Mouse CD20 & CD3e Bispecific Antibody (Iv0225)

Catalog #:   VMC90701 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: FuncS
Accession: P19437 & P22646
Overview

Catalog No.

VMC90701

Species reactivity

Mouse

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Bispecific, B-lymphocyte antigen CD20, B-cell differentiation antigen Ly-44, Lymphocyte antigen 44, Membrane-spanning 4-domains subfamily A member 1, CD20, Ms4a1, Cd20, Ly-44, Ms4a2, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, Cd3e

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P19437 & P22646

Applications

FuncS

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Iv0225

Data Image
References

Extracellular Vesicle-Derived MicroRNAs as a Biomarker for Therapeutic Response in Multiple Sclerosis., PMID:40537080

Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia., PMID:40536789

Rare Case of Primary Bone Lymphoma., PMID:40535393

Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies., PMID:40534489

Ovarian teratomas causing anti-N-methyl-D-aspartate receptor encephalitis: a case series from west China., PMID:40530142

Case Report: Unilateral relapsing primary central nervous system vasculitis-expanding the phenotype., PMID:40529356

Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphoma., PMID:40528731

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery., PMID:40528282

Inflammatory cells and remodeling in bronchial biopsies from COPD patients and controls., PMID:40526700

Treatment Options for the Comorbidity of Multiple Sclerosis With Other Chronic Inflammatory Diseases., PMID:40526577

Allogenic Transplantation of RPE Strips Lacking MHC Class II Can Avoid Rejection in Nonhuman Primate Eyes., PMID:40525923

Heavily Pretreated Refractory Diffuse Large B-Cell Lymphoma Successfully Treated with Epcoritamab: Case Report., PMID:40524964

The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomas., PMID:40524014

Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Update on Biology and Treatment., PMID:40517549

A Phase 2 Study of Obinutuzumab Combined with Lenalidomide in Previously Untreated High Tumor Burden Follicular Lymphoma., PMID:40517417

Beyond The Usual Suspects: Primary Breast Lymphoma Incidentally Detected With Routine Mammographic Screening., PMID:40517134

Evaluating the Role of CAR-T Cell Therapy in the Context of Current Therapy Options for Patients With Relapsed or Refractory Follicular Lymphoma., PMID:40516919

Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia., PMID:40515863

Native structure of the monoclonal therapeutic CD20 antibody ocrelizumab., PMID:40513927

Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective study., PMID:40512187

Pharmacokinetics, Receptor Occupancy, and Pharmacodynamics of Obexelimab Following Intravenous Administration in Adult Healthy Volunteers and in Patients With Rheumatoid Arthritis., PMID:40512061

Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis., PMID:40510879

Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3., PMID:40510503

Low-Dose Salinomycin Alters Mitochondrial Function and Reprograms Global Metabolism in Burkitt Lymphoma., PMID:40507936

Effectiveness of anti-CD20 therapies following natalizumab discontinuation: insights from a cohort study., PMID:40505538

The immunology and neuropathology of the autoimmune nodopathies., PMID:40505341

Lewis Acid-Boosted Nanozyme for In Situ Metallization Electrochemical Sensing of Extracellular Vesicles., PMID:40503912

Hairy Cell Leukemia With Splenic Rupture: Hematological Changes and Disappearance of Hairy Morphology After Splenectomy., PMID:40501519

QSP modeling of loncastuximab tesirine with T-cell-dependent bispecific antibodies guides dose-regimen strategy., PMID:40500294

[Methotrexate-related lymphoproliferative disease of the ileum with fistular formation between the small bowel and rectum:a case report]., PMID:40500207

CD4+ T-lymphocytes in human saccular intracranial aneurysm walls are associated with aneurysm rupture., PMID:40498464

A Rare Case of Follicular Lymphoma with both Malignant Pleural Effusion and Ascites., PMID:40497627

Causal Effects of Immune Cells on Reproductive Ill-Health, Including Abnormal Spermatozoa, Polycystic Ovary Syndrome and Spontaneous Abortion: Mendelian Randomization Analyses., PMID:40496872

Factors for Rituximab Refractoriness in AQP4-IgG+ NMOSD: A Cohort Study., PMID:40492601

CD20 targeted nanomedicine for GCB-diffuse large B-cell lymphoma through synergistic effects of apoptosis and ferroptosis., PMID:40492153

Indolent NK-Cell Lymphoproliferative Disorder of the Nasal Cavity: A Case Report and Review of the Literature., PMID:40491213

Causal association between blood and urine biomarkers, immune cells, and bladder cancer: A Mendelian randomization and mediation analysis., PMID:40489835

Orbital fibroblastic reticular cell tumor: A case report and literature review for a rare disease., PMID:40489805

Immunosuppressive agents in diabetes treatment: Hope or despair?, PMID:40487626

Primary Mediastinal Large B-cell Lymphoma: A Diagnostic Conundrum., PMID:40487560

Persistent B Cell Depletion After Rituximab for Autoimmune and Glomerular Diseases: A Case Series., PMID:40485690

Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective., PMID:40481170

Haemophagocytic lymphohistiocytosis (HLH) secondary to measles in an adult with a loss of post-vaccination humoral immunity following rituximab., PMID:40480240

Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies., PMID:40475129

The Role of Novel Immunomodulators in the Treatment of Autoimmune Hepatitis., PMID:40474885

Utilization of anti-CD20 antibodies for treatment of childhood nephrotic syndrome, 2010 to 2022., PMID:40473981

Advances in the treatment of ANCA-associated vasculitis., PMID:40473820

CD20×CD3 Bispecific Antibodies in B-NHL: A Review of Translational Science, Pharmacokinetics, Pharmacodynamics, and Dose Strategy in Clinical Research., PMID:40471801

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany., PMID:40470489

Effects of sample age and storage temperature on the flow cytometric diagnosis of chronic lymphocytic leukaemia in South Africa., PMID:40470130

Datasheet
$ 484
Product specifications
100 μg 484 1 mg 1932

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Mouse CD20 & CD3e Bispecific Antibody (Iv0225) [VMC90701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only